Ann: Preliminary Final Report FY2021 App 4E and Announcement, page-6

* demand has dropped right off
* still haven't said a word about the MODULATE trial which finished up 2 quarters ago
* Haven't announced the first patient in the ATTUNE study
* announced some weird capital return in relation to Merck that hasn't progressed anywhere in 7 years

They are in a much worse position than they're letting on, there are going to be some VERY cheap shares available shortly.

Snoozy should be about to award himself a pay rise any day now.